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Background: Hyponatremia (serum sodium concentration <135 mEq/L) is the most
common electrolyte abnormality among hospitalized patients. Our aim was to study the
epidemiology of hyponatremia in hospitalized patients, as well as the short-term mortality
rates, the length of stay (LOS), and associated hospital costs.
Methods: This retrospective cohort study included 6,539 hospitalizations in the
internal medicine ward of a Swiss tertiary-care teaching hospital between January 1,
2012, and December 31, 2018 (42.7% women, mean age 69 years). Using serum
sodium concentration, we identified hospitalizations with hyponatremia and calculated
the prevalence of overall hyponatremia, admission hyponatremia (AH), hospital-acquired
hyponatremia (HAH), and persistent hyponatremia (PH) at discharge. We also studied
the impact of hyponatremia on 30-day readmissions, in-hospital and 30-day mortality,
and hospital LOS and costs, using multivariable logistic regression and Cox proportional
hazards models, with normal natremia as reference.
Results: Prevalence of overall hyponatremia was 32.5% [95% confidence interval
(CI), 31.3–33.6%], while prevalence of PH among hospitalizations with AH and HAH
was 33.7% (31.7–35.8%). After multivariable adjustment, hyponatremia was associated
with increased hospital costs (CHF 19,025 ± 485 vs. 14,962 ± 341, p < 0.001) and
LOS (13.4 ± 0.2 vs. 10.7 ± 0.2 days, p < 0.001). Increased severity of hyponatremia
was associated with higher hospital costs and LOS (p for trend <0.001). There was
a trend toward more frequent 30-day readmissions associated with hyponatremia
[adjusted odds ratio (OR), 1.15 (1.01–1.31), p = 0.032], mainly with PH: adjusted
OR = 1.41 (1.17–1.71), p < 0.001. No association was found between severity
of hyponatremia and readmissions. Hyponatremia was associated with an increase
of in-hospital [adjusted OR = 1.94 (1.49–2.53), p < 0.001] and 30-day mortality:
adjusted OR = 1.80 (1.44–2.24), p < 0.001. Increased severity of hyponatremia
was associated with higher in-hospital and 30-day mortality (p for trend < 0.001).
Lu et al. Swiss Hospital Description of Hyponatremia
Conclusions: Hyponatremia is highly prevalent among hospitalized patients and
associated with an increase of LOS, early hospital readmission, in-hospital and 30-day
mortality, and hospital costs. PH was associated with a substantial increase of the risk
of early hospital readmission and 30-day mortality.
Keywords: hyponatremia, epidemiology, mortality, hospital costs, risk factors
BACKGROUND
Hyponatremia, usually defined as a serum sodium concentration
<135 mEq/L, is the most prevalent electrolyte abnormality
in hospitalized patients (1). The reported frequency of
hyponatremia varies according to the health-care setting,
the clinical circumstances, and the definition of hyponatremia
used but can affect up to 30% of patients in some series
(1–3). In a hospital setting, conditions that are associated
with hyponatremia include the syndrome of inappropriate
antidiuretic hormone secretion (SIADH) (4), congestive heart
failure, cirrhosis, chronic kidney disease, and use of specific
medications, such as thiazide diuretics (5, 6). Age is strongly
associated with hyponatremia, with a relative risk ranging from
1.54 for patients aged between 41 and 50, to 5.8 for patients aged
≥81 (7). Given the increasing age of patients hospitalized in
internal medicine wards in Western countries (8), the prevalence
of hyponatremia is expected to increase. Hyponatremia is also
associated with higher mortality: in a large multicentric study,
Zilberberg and colleagues found a 55% increase in the risk
of death in patients admitted with hyponatremia compared
with patients with normal natremia (9). Hyponatremia is also
associated with increased morbidity such as falls and fractures
(5), cognitive impairment and impaired quality of life (10),
increased length of stay (LOS) (11), hospitalization costs, and
use of medical resources (12).
Among hospitalized patients, hyponatremia can be either
present on admission or acquired during hospital stay. Up
to two thirds of hyponatremia cases may be hospital-acquired
(2). In Singapore, Hawkins and colleagues analyzed a large
database of over 120,000 patients and showed that the prevalence
of hyponatremia among hospitalized patients was 42%, with
28% at admission and 14% hospital-acquired (7). Hoorn and
colleagues reported that the occurrence of severe hyponatremia
during hospital stay was associated with inadequate management
and treatment-related factors such as thiazide diuretics, drugs
stimulating the secretion of antidiuretic hormone, hypotonic
intravenous fluids, and surgery (13).
Treatment of hyponatremia remains suboptimal despite
recommendations regarding its diagnosis and management. In
a US hospital, Donzé and colleagues reported that 42% of 4,195
patients with diagnoses of heart failure and hyponatremia on
admission still had hyponatremia at discharge (14). In this
particular setting, PH was associated with an increased rate of
readmission and 30-day mortality [odds ratio (OR) 1.45, 95%
confidence interval (CI): 1.27–1.67].
Apart from the previous study, few have examined the
consequences of persistent hyponatremia (PH) at discharge
(regardless of its etiology), namely, the risk of early hospital
readmission. Furthermore, few data on hyponatremia among
hospitalized patients exist in Switzerland. Hence, we performed
an observational, monocentric, retrospective study to
investigate the epidemiology of hyponatremia (including
the incidence of hospital-acquired and PH at discharge) among
hospitalized patients.
MATERIALS AND METHODS
Study Design and Patient Population
The study was designed as a retrospective cohort study
and conducted in the internal medicine service of Lausanne
University hospital (Centre hospitalier universitaire vaudois or
CHUV), a large tertiary referral center and teaching hospital in
Lausanne, Switzerland. This internal medicine service has 140
beds and receives over 4,000 admissions per year.
All patients aged ≥18 who stayed ≥24 h in the internal
medicine wards from January 1, 2012, to December 31, 2018,
were screened. For patients to be included, two conditions were
necessary: (1) to have signed the general consent for research
(Consentement général pour la recherche or CGR) form and (2) to
be transferred from the emergency department or the intensive
care unit (ICU). The CGR is required by the Swiss legislation on
research involving humans (Loi relative à la recherche sur l’être
humain) to use patients’ clinical and biological data for research
purposes. It complies with the ethical principles mentioned
in the Oviedo Convention, the Declaration of Helsinki, and
the Declaration of Taipei. The second inclusion criterion was
added because we did not have authorization from the local
Ethics Committee to include patients from other departments
(e.g., surgery departments). Moreover, in our institution, the
emergency department and the ICU account for the majority
of patients hospitalized in the internal medicine ward. Our
study was approved by the Cantonal Ethics Committee on
research involving humans (CER-VD, decision dated September
3, 2019).
Patients were excluded if (1) no serum sodium concentration
value was available in the first 24 h following admission; (2)
they were transferred from departments or wards other than
the emergency department or the ICU of the CHUV; or
(3) they were transferred to another ward, department, or
hospital (other than a rehabilitation unit) before the end of
acute care.
The following data were retrieved from patients’ electronic
medical records: age; gender; main diagnosis on discharge;
number of comorbidities; natremia on admission, during
hospitalization, and at discharge; LOS; status at discharge
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(alive/dead); and any 30-day readmission in any department of
the CHUV. Vital status at 30 days after discharge was retrieved
from the Swiss Federal Statistical Office data.
Hospitalization costs were extracted from the CHUV financial
database. The diagnosis-related group (DRG) system was also
used to evaluate hospitalization costs. The DRG system has been
in use in Switzerland since 2012. It classifies hospitalizations
into three categories on the basis of their LOS: “inlier” (LOS is
similar to nationwide average LOS for a given DRG), “highlier”
(LOS is longer than nationwide average LOS), and “lowlier”
(LOS is shorter than nationwide average LOS). Given the small
percentage of “lowliers” (<4%), they were included in the
‘‘inlier’’ group.
The main diagnoses were identified by extracting the
International Classification of Diseases, 10th revision (ICD-
10), codes in discharge letters, and were categorized into the
following groups: infectious diseases, cancers, pulmonary
diseases, cardiac diseases, liver diseases, neurological
diseases, endocrine disorders, psychiatric disorders, and
others (Supplementary Table 1). Kidney diseases represented
<0.5% of main diagnoses and were included in the “other
diagnoses” category.
All data were extracted and anonymized by the Data Science
& Research (DS&R) group, which is the only entity authorized
to extract data from the CHUV databases. After extraction, the
source database provided by the DS&R group was converted
into a statistical-friendly format. All modifications and analyses
were performed via programming, a new database was created,
and no changes were being made to the original database.
All files were stored in a secured server within the research
folder of the internal medicine ward. Access to this folder was
limited to the principal investigator and the persons in charge of
the analyses.
Endpoints
The main endpoint was the prevalence of overall hyponatremia,
admission hyponatremia (AH), hospital-acquired hyponatremia
(HAH), and PH.
Hyponatremia was defined as a serum sodium concentration
<135 mEq/L and further categorized into mild (130–135
mEq/L), moderate (125–129 mEq/L), and severe (<125 mEq/L)
(6). Hyponatremia at admission was defined by hyponatremia
evidenced during the first 24 h of hospitalization. HAH was
defined as hyponatremia diagnosed after the first 24 h of
hospitalization, with natremia within normal range (135–145
mEq/L) on admission. Overall hyponatremia was defined as AH
or HAH. Lastly, PH was defined as hyponatremia evidenced at
admission or after the first 24 h of hospitalization, and on the last
available blood test before discharge.
Secondary objectives included studying (1) the demographic
and clinical characteristics (age, gender, and main diagnosis
during hospitalization) associated with hyponatremia, with
normal natremia as reference; (2) the impact of hyponatremia
on hospital LOS and costs, 30-day readmissions, in-hospital all-
cause mortality, and all-cause 30-day mortality, using normal
natremia as reference.
Covariates
To account for potential confounders when comparing hospital
LOS and costs, readmissions, and all-cause mortality rates
between patients with and without hyponatremia, the following
covariates were selected on the basis of previous reports (14–
16): age group (four categories: <60, 60–69, 70–79, and >80
years old), gender, main diagnosis group (eight categories, as
mentioned above), and the number of comorbidities.
Statistical Analyses
Statistical analyses were conducted using Stata version 16.0 for
Windows R© (Stata Corp, College Station, TX, USA). As some
patients were hospitalized several times, the unit of analysis was
the total number of hospitalizations (and not the total number
of patients), unless specified otherwise. Results were expressed
as number and (percentage) for categorical variables and as
average ± standard deviation (SD) or as median [interquartile
range (IQR)] for continuous variables. Between-group bivariate
comparisons were performed using chi-square for categorical
variables and Student’s t-test, analysis of variance (ANOVA),
or Kruskal–Wallis test for continuous variables. As LOS and
costs showed a right-skewed distribution, a multivariable analysis
was performed on log-transformed values. Multivariable analyses
were conducted using multilevel mixed-effects linear regression
for continuous variables and multilevel mixed-effects logistic
regression for categorical variables to take into account multiple
hospitalizations for the same patient, or plain ANOVA and
logistic regression when single individual data were used. Results
were expressed as multivariable-adjusted mean ± standard error
for continuous variables and as multivariable-adjusted OR and
(95% CI) for categorical variables. For mortality analyses, only
the last hospitalization of each patient was considered. Mortality
was assessed using Cox regression, and results were expressed as
hazard ratios (HRs) and (95% CI) (17). Multivariable analyses
were performed adjusting for age (four categories), gender,
main cause for hospitalization (eight categories), and number of
associated comorbidities. Post-hoc trend analyses were performed
using the contrast p. command of Stata.
Due to the number of tests performed and as suggested by
others (18), a conservative value of 0.005 was used to define
statistical significance.
RESULTS
From January 1, 2012, to December 31, 2018, a total of 18,241
hospitalizations in the internal medicine wards of the CHUV,
with available sodium values in the first 24 h after admission,
were recorded. A total of 4,307 patients, representing 7,133
hospitalizations (35% of total hospitalizations), had signed
the CGR and were eligible for inclusion. A total of 594
hospitalizations were excluded because of missing data or
exclusion criteria, with 6,539 hospitalizations included in the
analyses. The characteristics of the included and excluded
hospitalizations are summarized in Supplementary Table 2:
included patients were significantly older and had significantly
shorter LOS.
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Prevalence and Determinants of
Hyponatremia
The trends and prevalence of overall, AH, HAH, and PH are
summarized in Table 1. Prevalence of AH was 24.7% (95% CI,
23.7–25.8%), and prevalence of HAH among participants devoid
of AH was 10.3% (95% CI, 9.4–11.1%). Interestingly, nearly
one third of patients had PH at discharge (33.7%). Most cases
of hyponatremia were mild (69.1%), with 20.2% moderate and
10.7% severe.
The demographic and clinical characteristics of
hospitalizations with and without hyponatremia are shown
in Table 2. Hospitalizations with severe hyponatremia had a
lower frequency of women and a lower frequency of subjects aged
<60. Furthermore, the main diagnoses on discharge groups were
significantly different according to the severity of hyponatremia,
with a higher proportion of endocrine disorders associated with
severe hyponatremia.
The demographic and clinical characteristics of
hospitalizations with and without PH are reported in
Supplementary Table 3. Hospitalizations with PH tended to
have a higher frequency of women and different main diagnosis
groups, while no differences were found for age groups.
Supplementary Table 4 shows the number of sodium
measurements and the natremia values, according to categories
of sodium levels. The number of measurements increased with
the severity of hyponatremia. Increases in natremia across
hospital stay were stronger among the most severe categories.
No differences were observed for PH as expressed by the median
rises of natremia from admission to discharge.
Hyponatremia, Length of Stay, Hospital
Costs, and Readmissions
The associations between natremia levels and hospital costs and
DRG categories are summarized in Table 3. Admissions with
hyponatremia incurred higher costs and were more frequently
DRG highliers than admissions with normal natremia, and this
difference persisted after a multivariate analysis. The severity
of hyponatremia was positively associated with an increase in
hospital costs and in the likelihood of being DRG highlier. Non-
PH was associated with an increase in hospital costs and the
likelihood of being DRG highlier, while PH was not.
The associations between natremia levels and LOS and 30-
day readmissions are summarized in Table 4. Admissions with
hyponatremia had a longer LOS and a 15% higher likelihood of
readmission. LOS increased with the severity of hyponatremia,
but no association was found between severity of hyponatremia
and readmission. Non-PH had a longer LOS while PH presented
a higher likelihood of readmission.
Hyponatremia and Mortality
The associations between hyponatremia and in-hospital or 30-
day mortality are summarized in Table 5. Overall hyponatremia
was associated with an almost doubling of in-hospital mortality,
and the association increased with the severity of the condition.
Similar findings were obtained for 30-day mortality. Non-PH
and PH were associated an increase of in-hospital and 30-day
mortality, the increase being stronger for PH.
DISCUSSION
The main results of our study are (1) hyponatremia was very
common in hospitalized patients, one patient out of four having
AH, one patient out of 10 developing HAH, and, among patients
with AH or HAH, one out of three (33.7%) having PH; (2)
hyponatremia was associated with increased readmissions, LOS,
hospital costs, in-hospital, and 30-day mortality.
Prevalence and Determinants of
Hyponatremia
The overall prevalence of hyponatremia in our study was close
to 33%, a value almost 10-fold higher than reported in a
previous retrospective study conducted in three hospitals in
Basel, Switzerland (368/10,500 admissions or 3.5%) (19). A
possible explanation is that the authors used diagnostic codes in
discharge letters to identify hyponatremia; this might have led to
TABLE 1 | Annual trends in the prevalence of hyponatremia: Lausanne University Hospital, 2012–2018.
2012 2013 2014 2015 2016 2017 2018 All
All hospitalizations 376 885 963 1,014 982 1,052 1,267 6,539
Hyponatremia, all
Overall 78 (20.7) 273 (30.9) 309 (32.1) 278 (27.4) 365 (37.2) 358 (34) 462 (36.5) 2,123 (32.5)
Admission 58 (15.4) 205 (23.2) 218 (22.6) 197 (19.4) 277 (28.3) 289 (27.6) 371 (29.3) 1,615 (24.7)
Hospital-acquireda 20 (6.3) 68 (10.0) 91 (12.2) 81 (9.9) 87 (12.4) 69 (9.1) 89 (10.0) 505 (10.3)
Persistentb 16 (20.5) 85 (31.1) 111 (35.9) 72 (25.9) 133 (36.4) 129 (36.0) 170 (36.8) 716 (33.7)
Severity of hyponatremia
Mild (130–135 mEq/L) 52 (66.7) 173 (63.4) 214 (69.3) 192 (69.1) 258 (70.7) 242 (67.6) 336 (72.7) 1,467 (69.1)
Moderate (125–129 mEq/L) 16 (20.5) 66 (24.2) 64 (20.7) 56 (20.1) 70 (19.2) 74 (20.7) 82 (17.8) 428 (20.2)
Severe (<125 mEq/L) 10 (12.8) 34 (12.5) 31 (10.0) 30 (10.8) 37 (10.1) 42 (11.7) 44 (9.5) 228 (10.7)
Results are expressed as number of hospitalizations (percentage).
aAmong hospitalizations without hyponatremia at admission.
bAmong hospitalizations with hyponatremia at admission or hospital-acquired hyponatremia.
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TABLE 2 | Demographic and clinical characteristics of hospitalizations according to categories of sodium levels.
All Normal Mild Moderate Severe p value
N 6,539 4,416 1,467 428 228
Women (%) 2,794 (42.7) 1,925 (43.6) 564 (38.5) 187 (43.7) 118 (51.8) <0.001
Age groups (%) <0.001
<60 1,561 (23.9) 1,036 (23.5) 378 (25.8) 104 (24.3) 43 (18.9)
60–69 1,340 (20.5) 817 (18.5) 343 (23.4) 120 (28.0) 60 (26.3)
70–79 1,597 (24.4) 1,095 (24.8) 352 (24.0) 93 (21.7) 57 (25.0)
≥80 2,041 (31.2) 1,468 (33.2) 394 (26.9) 111 (25.9) 68 (29.8)
Main diagnosis on discharge (%) <0.001
Pulmonary disease 1,669 (25.5) 1,228 (27.8) 333 (22.7) 79 (18.5) 29 (12.7)
Heart disease 1,121 (17.1) 826 (18.7) 195 (13.3) 56 (13.1) 44 (19.3)
Cancer 537 (8.2) 342 (7.7) 138 (9.4) 43 (10.1) 14 (6.1)
Neurological disease 326 (5.0) 234 (5.3) 57 (3.9) 22 (5.1) 13 (5.7)
Liver disease 211 (3.2) 86 (2.0) 89 (6.1) 22 (5.1) 14 (6.1)
Endocrine disorders 139 (2.1) 42 (1.0) 46 (3.1) 19 (4.4) 32 (14.0)
Psychiatric disorders 85 (1.3) 57 (1.3) 18 (1.2) 7 (1.6) 3 (1.3)
Other diseases 2,451 (37.5) 1,601 (36.3) 591 (40.3) 180 (42.1) 79 (34.7)
Hyponatremia values include acquired-hyponatremia and hospital-acquired hyponatremia: Lausanne University Hospital, 2012–2018.
Results are expressed as number of hospitalizations (percentage). Between-group comparisons performed using chi-square test.
TABLE 3 | Bivariate and multivariable analysis of the association between natremia levels and hospital costs or diagnosis-related group (DRG) categories: Lausanne
University Hospital, 2012–2018.
Hospital costs (CHF) Diagnosis-related group categories
Bivariate Multivariable Bivariate Multivariable
Median [IQR] p value Mean ± SE p value§ Inlier Highlier p value OR (95% CI) p value§
Natremia levels <0.001 <0.001 <0.001
Normal 10,299 [7,029–16,025] 14,962 ± 341 3,851 (69.6) 565 (56.3) 1 (reference)
Decreased 13,142 [8,644–22,586] 19,025 ± 485 1,684 (30.4) 439 (43.7) 1.66 (1.41–1.95) <0.001
Natremia levels <0.001 <0.001 <0.001
Normal 10,299 [7,029–16,025] 14,920 ± 340 3,851 (69.6) 565 (56.3) 1 (reference)
Mild (130–135 mEq/L) 12,610 [8,470–21,318] 17,516 ± 567 1,194 (21.6) 273 (27.2) 1.49 (1.24–1.78) <0.001
Moderate (125–129 mEq/L) 14,577 [9,789–26,675] 22,210 ± 1,030 317 (5.7) 111 (11.1) 2.19 (1.66–2.88) <0.001
Severe (<125 mEq/L) 14,628 [9,232–27,542] 23,395 ± 1,422 173 (3.1) 55 (5.5) 1.95 (1.34–2.82) <0.001
p value for trend < 0.001 < 0.001
Persistent hyponatremia <0.001 0.001 <0.001
Normal 10,299 [7,029–16,025] 14,966 ± 341 3,851 (69.6) 565 (56.3) 1 (reference)
Non-persistent 13,725 [9,073–24,295] 20,188 ± 582 1,084 (19.6) 323 (32.2) 1.90 (1.58–2.27) <0.001
Persistent 12,305 [7,932–18,851] 16,695 ± 807 600 (10.8) 116 (11.6) 1.23 (0.96–1.57) 0.109
p value for trend‡ 0.001 0.109
CHF, Swiss Francs; CI, confidence interval; IQR, interquartile range; OR, odds ratio; SE, standard error; Inlier, length of stay is similar to nationwide average for a given DRG; highlier,
length of stay is longer than nationwide average.
‡Multivariable model.
§Based on log-transformed data.
Results are expressed as median [interquartile range] or multivariable-adjusted mean ± standard error for continuous variables and as number of hospitalizations (percentage) or
multivariable-adjusted odds ratio (95% confidence interval) for categorical variables. Between-group bivariate analysis performed using Kruskal–Wallis test for continuous variables
and chi-square for categorical variables. Multivariable analysis conducted using multilevel mixed-effects linear regression for continuous variables and multilevel mixed-effects logistic
regression for categorical variables. Multivariable analyses were performed adjusting for age (four categories), gender, main cause for hospitalization (eight categories), and number of
associated comorbidities.
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TABLE 4 | Bivariate and multivariable analysis of the association between natremia levels and lengths of stay or 30-day unplanned readmissions: Lausanne University
Hospital, 2012–2018.
Length of stay (days) Readmissions
Bivariate Multivariable Bivariate Multivariable
Median [IQR] p value Mean ± SE p value§ No Yes p value OR (95% CI) p value
Natremia levels <0.001 <0.001 <0.001
Normal 8 [5–13] 10.7 ± 0.2 2,946 (69.4) 1,470 (64.1) 1 (reference)
Decreased 10 [7–17] 13.4 ± 0.2 1,301 (30.6) 822 (35.9) 1.15 (1.01–1.31) 0.031
Natremia levels <0.001 <0.001 <0.001
Normal 8 [5–13] 10.6 ± 0.2 2,946 (69.4) 1,470 (64.1) 1 (reference)
Mild (130–135 mEq/L) 10 [7–16] 12.6 ± 0.3 910 (21.4) 557 (24.3) 1.14 (0.98–1.31) 0.080
Moderate (125–129 mEq/L) 12 [8–20] 15.2 ± 0.5 253 (6.0) 175 (7.6) 1.22 (0.96–1.54) 0.106
Severe (<125 mEq/L) 12 [8–21] 16.1 ± 0.7 138 (3.3) 90 (3.9) 1.14 (0.82–1.56) 0.438
p value for trend < 0.001 0.381
Persistent hyponatremia <0.001 0.003 <0.001
Normal 8 [5–13] 10.7 ± 0.2 2,946 (69.4) 1,470 (64.1) 1 (reference)
Non-persistent 11 [7–19] 14.2 ± 0.3 890 (21) 517 (22.6) 1.04 (0.89–1.20) 0.644
Persistent 10 [6–15] 11.9 ± 0.4 411 (9.7) 305 (13.3) 1.41 (1.17–1.71) <0.001
p value for trend‡ 0.003 <0.001
CI, confidence interval; IQR, interquartile range; OR, odds ratio; SE, standard error.
‡Multivariable model.
§Based on log-transformed data.
Results are expressed as median [interquartile range] or multivariable-adjusted mean ± standard error for continuous variables and as number of hospitalizations (percentage) or
multivariable-adjusted odds ratio (95% confidence interval) for categorical variables. Between-group bivariate analysis performed using Kruskal–Wallis test for continuous variables
and chi-square for categorical variables. Multivariable analysis conducted using multilevel mixed-effects linear regression for continuous variables and multilevel mixed-effects logistic
regression for categorical variables. Multivariable analyses were performed adjusting for age (four categories), gender, main cause for hospitalization (eight categories), and number of
associated comorbidities.
an underestimation, as hyponatremia is usually underreported in
hospital codifications (20). Conversely, our estimation is in the
same range as previous reports: Hawkins using data from over
120,000 patients in a Singaporean hospital, found a prevalence of
hyponatremia of ∼42% (7); Hoorn et al. using data from 2,900
patients in a Dutch hospital, reported an incidence of hospital-
associated hyponatremia of ∼30% (13). Hence, our results
suggest that hyponatremia (all types) is a common condition
among patients hospitalized in internal medicine.
A striking finding was the relatively high rate of HAH
and PH. In a previous single-center study including 53,236
hospitalizations, Wald et al. found an even higher incidence
of HAH (38.2%) (15), which may be partly explained by the
use of different cutoff values: hyponatremia was defined as
serum sodium concentration <138 mEq/L. Concerning PH,
Donzé et al. found an incidence of 41.9% among 4,295 patients
hospitalized with a diagnosis of congestive heart failure (14),
while Greenberg and colleagues, in a large multicentric American
and European prospective study, reported that as many as 78%
of patients, initially hospitalized with hypervolemic or euvolemic
hyponatremia, still had PH at discharge (21). The mechanisms
underlying HAH and PH are probably different, as HAH may be
the marker of a transient event during hospitalization while PH
is possibly the marker of a chronic disease. The high prevalence
of HAH may be due to several factors such as a lack of medical
awareness, inaccurate diagnostic, and volume status assessment
(21, 22), and lack of a hospital warning system (13), while PH
may be partly due to variable effectiveness of available treatments
(6) or the fact that hyponatremia is frequently considered as the
consequence of an underlying disorder (which diverts attention
from hyponatremia itself).
Hyponatremia, Lengths of Stay, Hospital
Costs, and Readmissions
Hyponatremia was associated with increased LOS and
hospitalization costs, a finding in agreement with the literature
(1, 9, 15). In a large meta-analysis including almost 4,000,000
patients from the United States and Europe, Corona et al.
reported that hyponatremia was associated with an increase of
LOS (+3.30 days, 95% CI, 2.90–3.71) and of hospital costs up to
$3,000 compared with normonatremia (23). Our study extended
these data by adding there was a “dose–response” relationship
between LOS or hospitalization costs, and the severity of
hyponatremia. In a Swiss setting, Althaus and Krapf found a
median average LOS of 9 days, which was slightly lower to ours
(19). However, the study was not limited to internal medicine
wards and may have included patients with fewer comorbidities.
The severity of the hyponatremia was not significantly
associated with the risk of early readmission. However,
hyponatremia overall was associated with an increased risk
of early hospital readmission, as was PH, but not non-PH.
Accordingly, the last in-hospital sodium level is part of the
HOSPITAL score, which has been developed to predict 30-day
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TABLE 5 | Bivariate and multivariable analysis of the association between natremia levels and in-hospital or 30-day mortality: Lausanne University Hospital, 2012–2018.
In-hospital mortality 30-day mortality
Bivariate Multivariable Bivariate Multivariable
Alive Dead p value HR (95% CI) p value Alive Dead p value HR (95% CI) p value
Natremia levels <0.001
Normal 2,560 (68.2) 138 (50.2) 1 (reference) 2,473 (68.5) 225 (53.2) <0.001 1 (reference)
Decreased 1,196 (31.8) 137 (49.8) 1.82 (1.43–2.33) <0.001 1,135 (31.5) 198 (46.8) 1.68 (1.37–2.04) <0.001
Natremia levels <0.001
Normal 2,560 (68.2) 138 (50.2) 1 (reference) 2,473 (68.5) 225 (53.2) <0.001 1 (reference)
Mild (130–135 mEq/L) 825 (22) 78 (28.4) 1.48 (1.12–1.97) 0.007 792 (22.0) 111 (26.2) 1.34 (1.06–1.69) 0.013
Moderate (125–129 mEq/L) 230 (6.1) 38 (13.8) 2.54 (1.75–3.67) <0.001 209 (5.8) 59 (14.0) 2.52 (1.88–3.39) <0.001
Severe (<125 mEq/L) 141 (3.8) 21 (7.6) 3.00 (1.88–4.79) <0.001 134 (3.7) 28 (6.6) 2.47 (1.65–3.69) <0.001
p value for trend <0.001 <0.001
Persistent hyponatremia <0.001
Normal 2,560 (68.2) 138 (50.2) 1 (reference) 2,473 (68.5) 225 (53.2) 1 (reference)
Non-persistent 797 (21.2) 77 (28.0) 1.57 (1.18–2.09) 0.002 767 (21.3) 107 (25.3) 1.39 (1.09–1.76) 0.007
Persistent 399 (10.6) 60 (21.8) 2.29 (1.68–3.12) <0.001 368 (10.2) 91 (21.5) 2.20 (1.72–2.83) <0.001
p value for trend‡ <0.001 <0.001
HR, hazard ratio; CI, confidence interval.
‡Multivariable model.
Results are expressed as number (column percentage) for bivariate comparisons and as multivariable-adjusted odds ratio and (95% confidence interval) for multivariable comparisons.
Between-group comparisons performed using chi-square (bivariate) and Cox regression (multivariable). Multivariable analyses were performed adjusting for age (four categories), gender,
main cause for hospitalization (eight categories), and number of associated comorbidities.
potentially avoidable hospital readmissions (24). Importantly, the
risk of early hospital readmission was mainly found for PH,
as opposed to normalized natremia on discharge. This again
highlights the fact that PH should not be overlooked before
discharging patients.
Hyponatremia and Mortality
Our in-hospital and 30-day mortality rates were in the same
range as previous reports: Wald et al. reported AH and HAH
(with hyponatremia defined as serum sodium concentration
<138 mEq/L) to be associated with an increase of in-hospital
mortality [respectively adjusted OR of 1.52 (95% CI, 1.36–
1.69) and adjusted OR of 1.66 (95% CI, 1.39–1.98)] (15), while
Holland-Bill et al. in a large Danish study including 41,803
hospitalized patients, found hyponatremia to be associated with
an increased 30-day mortality risk [adjusted relative risk, 1.5
(95% CI, 1.4–1.5)] (25). In our study, in-hospital mortality was
significantly increased, even in cases of mild hyponatremia,
while PH was associated with a substantial increase of 30-day
mortality. Compared with AH, HAH was associated with a 66%
increase in the adjusted odds of in-hospital mortality. Whether
hyponatremia by itself contributes to mortality or reflects the
severity of the underlying diseases remains unclear. We also
observed a “dose–response” relationship between in-hospital or
30-day mortality risk, and hyponatremia severity, in contrast
with what was previously published (25).
Implications for Clinical Practice
Whether hyponatremia should solely be considered as a simple
consequence of another disease or as amain issue in itself remains
to this day debatable (26). Further studies are needed to establish
if rapid diagnosis, close clinical, and biological monitoring, and
adequate management of hyponatremia could reduce short-term
mortality risk, LOS and associated costs, and early readmission
and improve quality of life. Accurate clinical volume status (22)
and the use of specific and complete testing [for example, urine
and plasma osmolality, as well as urine sodium at a minimum
for a proper diagnosis of SIADH (6)] are paramount. Moreover,
outpatient follow-up should not be overlooked, as close follow-
up visits may help to prevent relapse and development of chronic
hyponatremia (19).
Strengths and Limitations
This study has several strengths. Firstly, it is based on a cohort
of patients with a wide array of comorbid conditions, from
an acute care setting, who had complete available follow-up
data, via hospital and government registries. The size of the
cohort allowed us to explore multiple outcomes related to
hyponatremia while adjusting for variable potential confounders.
We were able to investigate less studied outcomes, such as
the proportion of PH and the risk of early readmission,
in addition to studying common endpoints usually described
in hyponatremia (prevalence, risk of mortality, and LOS).
Secondly, contrary to several previous studies, which used
diagnostic codes in discharge letters to identify patients with
hyponatremia, we were able to directly use plasma sodium levels
in our analyses. Using diagnostic codes, only, may lead to an
underestimation, as hyponatremia is usually underreported in
hospital codifications (20).
This study has several limitations. Firstly, the study was
conducted in a single center in a high-volume Swiss tertiary
hospital and may not be applicable to other settings. Still, the
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characteristics of the patients are similar to those found in
general internal medicine wards. Secondly, almost two thirds
of patients eligible were excluded because they did not sign
the CGR. This might have created a selection bias, as younger
people tend to provide consent more frequently (27); still, the
direction and magnitude of the bias are hard to estimate. Thirdly,
our epidemiological study was limited in the identification of
important clinical and biological determinants of hyponatremia
(volume status, plasma and urine electrolytes, and osmolality),
which are critical to understand its diagnostic, therapeutic,
and prognosis significations. Also, a causal relation between
hyponatremia and the main diagnosis and/or underlying medical
conditions cannot be concluded. Finally, we did not assess
medical therapy on admission and during hospital stay. Indeed,
medical therapy on admission is not systematically documented
in the software used in our institution. Moreover, when medical
therapy on admission is documented, it may not be reliable. Since
therapy on admission was unavailable, we chose not to include
therapy received during hospital stay either, because analyzing
the association between hospital treatment only and all categories
of hyponatremia (AH, HAH, and PH) would be challenging.
Therefore, we were unable to analyze if some of the cases of
hyponatremia were iatrogenic or if inadequate management was
partly responsible for PH. Knowing the causative diagnosis and
the determinant factors for PH as well as knowing the reasons for
readmission and 30-day mortality would be critical to improve
our understanding and the treatment of these patients.
CONCLUSIONS
Hyponatremia remains highly prevalent among hospitalized
patients and associated with an increase of early hospital
readmission, in-hospital and 30-day mortality, LOS, and hospital
costs. PH was associated with a substantial increase of the risk of
early hospital readmission and 30-day mortality.
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